Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Algernon Pharmaceuticals Provides Update March 11, 2021

View:

Post by B52paul on Mar 11, 2021 7:50am

Algernon Pharmaceuticals Provides Update March 11, 2021

https://www.globenewswire.com/news-release/2021/03/11/2191278/0/en/Algernon-Pharmaceuticals-Provides-Update-on-Timing-of-Topline-Results-for-Phase-2b-3-COVID-19-Trial-of-Ifenprodil.html

160

Comment

Comment by B52paul on Mar 11, 2021 7:59am

March 11, 2021 07:41 ET | Source: Algernon Pharmaceuticals VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, announces that it expects to report its topline results for the Phase 2b ...more

169

Comment

Algernon Pharmaceuticals Inc.